CalciMedica (CALC) Institutional Ownership $2.56 +0.02 (+0.79%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$2.56 0.00 (0.00%) As of 01/31/2025 06:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for CalciMedica (NASDAQ:CALC)Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$399.87KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$28.96K Get CALC Insider Trade Alerts Want to know when executives and insiders are buying or selling CalciMedica stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CALC Institutional Buying and Selling by Quarter CalciMedica Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/25/2024PVG Asset Management Corp15,115$67K0.3%N/A0.112% 11/16/2024Geode Capital Management LLC66,553$295K0.0%+51.2%0.619% 11/5/2024BML Capital Management LLC153,887$682K0.4%-4.1%1.432% 11/1/2024Atria Investments Inc26,503$117K0.0%+136.5%0.247% 4/23/2024BML Capital Management LLC160,424$667K0.4%+10.3%1.494% 2/2/2024 Meritage Portfolio Management46,000$132K0.0%+360.0%0.810% 1/30/2024BML Capital Management LLC145,424$416K0.3%+63.8%2.560% 12/7/2023Hudson Bay Capital Management LP166,857$432K0.0%N/A2.938% 7/31/2023 Meritage Portfolio Management10,000$40K0.0%N/A0.177% 7/24/2023BML Capital Management LLC88,781$356K0.3%N/A1.568% (Data available from 1/1/2016 forward) CALC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CALC shares? During the previous two years, the following institutional investors and hedge funds held shares of CalciMedica shares: BML Capital Management LLC ($682K), Hudson Bay Capital Management LP ($432K), Geode Capital Management LLC ($295K), Meritage Portfolio Management ($132K), and Atria Investments Inc ($117K), PVG Asset Management Corp ($67K).Learn more on CALC's institutional investors. Which institutional investors have been buying CalciMedica stock? The following institutional investors have purchased CalciMedica stock in the last 24 months: Hudson Bay Capital Management LP ($166.86K), BML Capital Management LLC ($160.42K), Meritage Portfolio Management ($46K), Geode Capital Management LLC ($22.53K), Atria Investments Inc ($15.30K), and PVG Asset Management Corp ($15.12K). How much institutional buying is happening at CalciMedica? Institutional investors have bought a total of 426,217 shares in the last 24 months. This purchase volume represents approximately $1.40M in transactions. Which CalciMedica major shareholders have been selling company stock? The following institutional investors have sold CalciMedica stock in the last 24 months: BML Capital Management LLC ($6.54K). How much institutional selling is happening at CalciMedica? Institutional investors have sold a total of 6,537 shares in the last 24 months. This volume of shares sold represents approximately $28.96K in transactions. Related Companies Sutro Biopharma Major Shareholders scPharmaceuticals Major Shareholders Protalix BioTherapeutics Major Shareholders Bright Minds Biosciences Major Shareholders Coherus BioSciences Major Shareholders Zentalis Pharmaceuticals Major Shareholders Artiva Biotherapeutics Major Shareholders Checkpoint Therapeutics Major Shareholders Silence Therapeutics Major Shareholders Cidara Therapeutics Major Shareholders This page (NASDAQ:CALC) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CalciMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CalciMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
